Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 3/2021

01-04-2021 | Colchicine | IM - REVIEW

Recurrent pericarditis: an update on diagnosis and management

Authors: Alessandro Andreis, Massimo Imazio, Matteo Casula, Stefano Avondo, Antonio Brucato

Published in: Internal and Emergency Medicine | Issue 3/2021

Login to get access

Abstract

Recurrent pericarditis is a true challenge for clinicians, especially when the patient becomes unresponsive or not tolerant to conventional treatments. An accurate diagnosis of recurrent pericarditis, possibly supported by advanced imaging tools, is critical to provide timely and appropriate treatment of symptoms and prevention of further episodes. The incessant research on the inflammatory pathways underlying cardiovascular diseases, led recently to the assessment of anti interleukin-1 agents in the setting of recurrent pericarditis. This review will focus on the diagnostic assessment of recurrent pericarditis, along with the most modern therapeutic advances in this field. Bibliographic databases were searched (MEDLINE/PubMed, BioMed Central, the Cochrane Collaboration Database of Randomized Trials, Scopus, ClinicalTrials.gov, EMBASE, Google Scholar) using the terms “recurrent pericarditis” AND “diagnosis” OR “treatment” OR “IL-1” OR “inflammation”.
Literature
1.
2.
Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987–1991PubMedCrossRef
3.
Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, Trinchero R, Spodick DH, Adler Y, CORP (COlchicine for Recurrent Pericarditis) Investigators (2011) Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 155:409–414PubMedCrossRef
4.
Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F, Demarie D, Ferro S, Forno D, Maestroni S, Cumetti D, Varbella F, Trinchero R, Spodick DH, Adler Y (2014) Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 383:2232–2237PubMedCrossRef
5.
6.
Imazio M, Trinchero R, Shabetai R (2007) Pathogenesis, management, and prevention of recurrent pericarditis. J Cardiovasc Med (Hagerstown) 8:404–410CrossRef
7.
Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R (2005) Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 112:2012–2016PubMedCrossRef
8.
Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, Demarie D, Forno D, Ferro S, Maestroni S, Belli R, Trinchero R, Spodick DH, Adler Y, ICAP Investigators (2013) A randomized trial of colchicine for acute pericarditis. N Engl J Med 369:1522–1528PubMedCrossRef
9.
Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL et al (2020) Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study. Eur J Prev Cardiol. 27(9):956–964PubMedCrossRef
10.
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W, ESC Scientific Document Group (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921–2964PubMedPubMedCentralCrossRef
11.
Imazio M, Gaita F, LeWinter M (2015) Evaluation and treatment of pericarditis: a systematic review. JAMA 314:1498–1506PubMedCrossRef
12.
Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, Leuzzi S, Cecchi E, Trinchero R, Adler Y (2009) Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 10:217–230CrossRef
13.
14.
Imazio M, Hoit BD (2013) Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol 168:648–652PubMedCrossRef
15.
16.
Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, Pomari F, Coda L, Belli R, Trinchero R (2007) Indicators of poor prognosis of acute pericarditis. Circulation 115:2739–2744PubMedCrossRef
17.
Lazaros G, Antonopoulos AS, Lazarou E, Vlachopoulos C, Vogiatzi G, Vassilopoulos D, Tousoulis D (2021) Age and sex-based differences in patients with acute pericarditis. Eur. J Clin Invest. 51:e13392
18.
Sreenivasan J, Khan MS, Hooda U, Khan SU, Aronow WS, Mookadam F, Krasuski RA, Cooper HA, Michos ED, Panza JA. Rate, Causes, and Predictors of 30-Day Readmission Following Hospitalization for Acute Pericarditis. Am J Med. 2020;133(12):1453-1459.e1
19.
20.
21.
Imazio M. Le malattie del pericardio. Diagnosi e terapia. Il Pensiero Scientifico Editore; 2016.
22.
23.
Farand P, Bonenfant F, Belley-Côté EP, Tzouannis N (2010) Acute and recurring pericarditis: More colchicine, less corticosteroids. World J Cardiol 2:403–407PubMedPubMedCentralCrossRef
24.
Kytö V, Sipilä J, Rautava P (2014) Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation 130:1601–1606PubMedCrossRef
25.
Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R, Adler Y (2011) Risk of constrictive pericarditis after acute pericarditis. Circulation. 124:1270–5PubMedCrossRef
26.
Krasic S, Prijic S, Ninic S, Borovic R, Petrovic G, Stajevic M, Nesic D, Dizdarevic I, Djordjevic N, Vukomanovic V. Predictive factors of recurrence after pediatric acute pericarditis. J Pediatr (Rio J). 2020;29:S0021-7557(20)30190-X.
27.
Imazio M, Colopi M, De Ferrari GM (2020) Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes. Heart 106:569–574PubMedCrossRef
28.
Avondo S, Andreis A, Casula M, Imazio M. Update on diagnosis and management of neoplastic pericardial disease. Expert Rev Cardiovasc Ther. 2020;18:615–623
29.
Andreis A, Imazio M, Giustetto C, Brucato A, Adler Y, Ferrari GMD. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis. Heart. 2020;106:1561–1565
30.
Imazio M, Brucato A, Spodick DH, Adler Y (2014) Prognosis of myopericarditis as determined from previously published reports. J Cardiovasc Med (Hagerstown) 15:835–839CrossRef
31.
Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, Hung J, Garcia MJ, Kronzon I, Oh JK, Rodriguez ER, Schaff HV, Schoenhagen P, Tan CD, White RD (2013) American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 26:965-1012.e15PubMedCrossRef
32.
Lazaros G, Imazio M, Brucato A, Tousoulis D (2016) Untying the Gordian knot of pericardial diseases: a pragmatic approach. Hellenic J Cardiol 57:315–322PubMedCrossRef
33.
Xu B, Kwon DH, Klein AL (2017) Imaging of the pericardium: a multimodality cardiovascular imaging update. Cardiol Clin 35:491–503PubMedCrossRef
34.
35.
Imazio M, Demichelis B, Parrini I, Cecchi E, Pomari F, Demarie D, Gaschino G, Ghisio A, Belli R, Trinchero R (2004) Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis. Am J Cardiol 94:973–975PubMedCrossRef
36.
Imazio M, Pivetta E, Palacio Restrepo S, Sormani P, Pedrotti P, Quarta G, Brucato A, Bubbico E, Dal Corso M, Milazzo A, Quattrocchi G, Andriani M, Lobetti Bodoni L, Davini O, Sironi S, Giannattasio C, Giustetto C, Bogaert J, Adler Y, Bucciarelli Ducci C, De Ferrari GM (2020) Usefulness of cardiac magnetic resonance for recurrent pericarditis. Am J Cardiol 125:146–151PubMedCrossRef
37.
Kumar A, Sato K, Yzeiraj E, Betancor J, Lin L, Tamarappoo BK, Kwon DH, Hachamovitch R, Klein AL (2017) Quantitative pericardial delayed hyperenhancement informs clinical course in recurrent pericarditis. JACC Cardiovasc Imaging 10:1337–1346PubMedCrossRef
38.
Cremer PC, Kumar A, Kontzias A, Tan CD, Rodriguez ER, Imazio M, Klein AL (2016) Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol 68:2311–2328PubMedCrossRef
39.
Alraies MC, AlJaroudi W, Yarmohammadi H, Yingchoncharoen T, Schuster A, Senapati A, Tariq M, Kwon D, Griffin BP, Klein AL (2015) Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am J Cardiol 115:542–547PubMedCrossRef
40.
41.
Gerardin C, Mageau A, Benali K, Jouan F, Ducrocq G, Alexandra J-F, van Gysel D, Papo T, Sacre K (2018) Increased FDG-PET/CT pericardial uptake identifies acute pericarditis patients at high risk for relapse. Int J Cardiol 271:192–194PubMedCrossRef
42.
43.
Andreis A, Imazio M, De Ferrari GM. Colchicine for the treatment of cardiovascular diseases: old drug, new targets. J Cardiovasc Med (Hagerstown) 2020;
44.
Millaire A, Ducloux G (1991) Treatment of acute or recurrent pericarditis with colchicine. Circulation. 1991;83:1458–9.PubMedCrossRef
45.
Imazio M, Brucato A, Belli R, Forno D, Ferro S, Trinchero R, Adler Y (2014) Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 - systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 15:840–846CrossRef
46.
Andreis A, Imazio M, Avondo S, Casula M, Paneva E, Piroli F, De Ferrari GM. Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials. J Cardiovasc Med (Hagerstown) 2021; 21.
47.
Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y (2009) Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30:532–9.PubMedCrossRef
48.
Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, Maestroni S, Cecchi E, Belli R, Palmieri G, Trinchero R (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671PubMedCrossRef
49.
Imazio M, Adler Y, Charron P (2016) Recurrent pericarditis: modern approach in 2016. Curr Cardiol Rep 18:50PubMedCrossRef
50.
Imazio M, Adler Y (2013) Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev 18:355–360PubMedCrossRef
51.
Imazio M, Brucato A, Lazaros G, Andreis A, Scarsi M, Klein A, De Ferrari GM, Adler Y (2020) Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality. J Cardiovasc Med 21:625–629CrossRef
52.
Lazaros G, Antonatou K, Vassilopoulos D (2017) The therapeutic role of interleukin-1 inhibition in idiopathic recurrent pericarditis: current evidence and future challenges. Front Med (Lausanne) 4:78CrossRef
53.
Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D (2018) Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med 13:475–489PubMedCrossRef
54.
Vianello F, Cinetto F, Cavraro M, Battisti A, Castelli M, Imbergamo S, Marcolongo R (2011) Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 147:477–478PubMedCrossRef
55.
del Fresno MR, Peralta JE, Granados MÁ, Enríquez E, Domínguez-Pinilla N, de Inocencio J (2014) Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics 134:e1441-1446PubMedCrossRef
56.
Lazaros G, Antonopoulos AS, Antonatou K, Skendros P, Ritis K, Hadziyannis E, Lazarou E, Leontsinis I, Simantiris S, Vlachopoulos C, Tousoulis D, Vassilopoulos D (2020) Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: a pilot observational prospective study. Int J Cardiol 311:77–82PubMedCrossRef
57.
Tombetti E, Mulè A, Tamanini S, Matteucci L, Negro E, Brucato A, Carnovale C (2020) Novel pharmacotherapies for recurrent pericarditis: current options in 2020. Curr Cardiol Rep 22:59PubMedPubMedCentralCrossRef
58.
Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M, Finetti M, Cumetti D, Carobbio A, Ruperto N, Marcolongo R, Lorini M, Rimini A, Valenti A, Erre GL, Sormani MP, Belli R, Gaita F, Martini A (2016) Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA 316:1906–1912PubMedCrossRef
59.
Epçaçan S, Sahin S, Kasapcopur O (2019) Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab. Cardiol Young 29:549–551PubMedCrossRef
60.
Kougkas N, Fanouriakis A, Papalopoulos I, Bertsias G, Avgoustidis N, Repa A, Sidiropoulos P (2018) Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. Rheumatology (Oxford) Oxford Academic 57:1494–1495
61.
Klein AL, Imazio M, Brucato A, Cremer P, LeWinter M, Abbate A, Lin D, Martini A, Beutler A, Chang S, Fang F, Gervais A, Perrin R, Paolini JF (2020) RHAPSODY: rationale for and design of a pivotal phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditis. Am Heart J 228:81–90PubMedCrossRef
62.
Khandaker MH, Schaff HV, Greason KL, Anavekar NS, Espinosa RE, Hayes SN, Nishimura RA, Oh JK (2012) Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc 87:1062–1070PubMedPubMedCentralCrossRef
63.
Andreis A, Imazio M, de Ferrari GM (2019) Contemporary diagnosis and treatment of recurrent pericarditis. Expert Rev Cardiovasc Ther 17:817–826PubMedCrossRef
64.
Karatolios K, Pankuweit S, Richter A, Ruppert V, Maisch B (2016) Anticardiac antibodies in patients with chronic pericardial effusion. Dis Markers 2016:9262741PubMedPubMedCentralCrossRef
65.
Caforio ALP, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, Bottaro S, Tona F, Betterle C, Daliento L, Thiene G, Iliceto S (2010) Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 96:779–784PubMedCrossRef
66.
Jara Calabuig I, Sánchez Soriano RM, Marco Domingo TF, Pérez Ortiz C, Chamorro Fernández AJ, Chamorro Fernández CI (2017) Recurrent pericarditis as the presenting form of adult still’s disease. Rev Esp Cardiol 70:208–209PubMedCrossRef
67.
Lopalco G, Rigante D, Cantarini L, Imazio M, Lopalco A, Emmi G, Venerito V, Fornaro M, Frediani B, Nivuori M, Brucato A, Iannone F. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment. Trends Cardiovasc Med 2020;
Metadata
Title
Recurrent pericarditis: an update on diagnosis and management
Authors
Alessandro Andreis
Massimo Imazio
Matteo Casula
Stefano Avondo
Antonio Brucato
Publication date
01-04-2021
Publisher
Springer International Publishing
Keyword
Colchicine
Published in
Internal and Emergency Medicine / Issue 3/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-021-02639-6

Other articles of this Issue 3/2021

Internal and Emergency Medicine 3/2021 Go to the issue

IM - ORIGINAL

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience

IM - COMMENTARY

Adverse drug reactions in the era of COVID-19

Correction

Correction to: Teen suicide: an underreported and emerging plague

IM - ORIGINAL

Association of overlap syndrome with incident atrial fibrillation

IM - COMMENTARY

The tale of refractory recurrent pericarditis

CE - Physical Examination

Intracranial bruits in meningitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits